WallStreetInvestorNews.com's Watch List Issued for 9/27/12: SRGE, PRTN, APDN, MCET
27 Septiembre 2012 - 11:01AM
Marketwired
WallStreetInvestorNews.com "Active Stocks to Watch for 09/27/12":
Southridge Enterprises Inc. (PINKSHEETS: SRGE), Pristine Solutions
Inc. (OTCQB: PRTN), Applied DNA Sciences Inc. (OTCQB: APDN),
MultiCell Technologies, Inc. (OTCQB: MCET)
Get the inside track and the latest Hot Tips with our Premium
News Alerts that are FREE for a limited time
http://www.wallstreetinvestornews.com or subscribe to our Youtube
Channel (http://www.youtube.com/user/wallstreetinvestorne)
Thursday morning, after the market opened for trading,
Southridge Enterprises Inc. (PINKSHEETS: SRGE) announced it has
added the expertise of Mexican industry professionals Mr. Alejandro
De Leon Garcia, Mr. Alfonso Sanchez Navarro and Mr. Salvador
Martinez Moreno to its board of Directors.
"We are extremely fortunate to have these three gentlemen join
the board of directors of Southridge, during this critical period
of our Company's development in Mexico. With over 45 years of
combined experience, Mr. De Leon Garcia, Mr. Sanchez Navarro and
Mr. Martinez Moreno will facilitate and expedite bringing our Gold
& Silver mines into full production capacity," said Michael
Davies, President of Southridge.
In other recent developments, the Company has now engaged the
necessary professional services to migrate and up-list the
Company's reporting status back to the Over-The-Counter Bulletin
Board. It is anticipated that this process will be complete before
the end of 2012.
Read the entire SRGE press release along with our full
disclosure:
http://wallstreetinvestornews.com/southridge-adds-mexican-industry-professionals-to-board/
Get the inside track and the latest hot tips with our Premium
News Alerts that are Free for a limited time;
http://wallstreetinvestornews.com.
Pristine Solutions, Inc. (OTCQB: PRTN) through its wholly-owned
subsidiary company, Eaton Scientific Systems, Ltd., holds the
intellectual property and global marketing rights to Tropine 3, a
patent pending novel indication of an existing FDA approved drug
for the non-hormonal treatment of hot flashes in pre-menopausal,
peri-menopausal, and post-menopausal women. The company is
preparing for Phase 1 & 2 Clinical Trials with the goal of FDA
approval of Tropine 3.
Applied DNA Sciences, Inc. (OTCQB: APDN) is a provider of
botanical-DNA based security and authentication solutions that can
help protect products, brands and intellectual property of
companies, governments and consumers from theft, counterfeiting,
fraud and diversion. SigNature® DNA and smartDNA, our principal
anti-counterfeiting and product authentication solutions that
essentially cannot be copied, provide a forensic chain of evidence
and can be used to prosecute perpetrators.
MultiCell Technologies, Inc. (OTCQB: MCET) is pleased to
announce the acceptance by the American Society for Cell Biology
(ASCB) of abstract "Short Synthetic Double Stranded RNA with Dual
Activity - Oncolytic and Immune Modulatory - for Hepatocellular
Carcinoma."
Disclaimer: Wall Street Investor Communications Inc. (WSICI),
also doing business as Wall Street Investor News, disseminates
electronic information to subscribers through its network of
affiliated companies and/or partners. WSICI is not a registered
broker/dealer. WSICI is an advertising and marketing company, and
as such may not sell, offer to sell or offer to buy any security.
WSICI profiles are not a solicitation or recommendation to buy,
sell or hold securities. An offer to buy or sell can be made only
with accompanying disclosure documents from the company offering or
selling securities and only in the states and provinces for which
they are approved. The material in this release is intended to be
strictly informational. The companies that are discussed in this
release may or may not have approved the statements made in this
release and may or may not have approved the timing of this
release. All statements and expressions are the sole opinion of
WSICI and are subject to change without notice. Information in this
release is derived from a variety of sources that may or may not
include the referenced company's publicly disseminated information,
information supplied by third parties or WSICI's own research. The
accuracy or completeness of the information is not warranted and is
only as reliable as the source from which it was obtained. While
this information is believed to be reliable, such reliability
cannot be guaranteed. WSICI disclaims and all liability as to the
completeness or accuracy of the information contained and any
omissions of material fact in this release. The release may contain
technical inaccuracies or typographical errors. It is strongly
recommended that any purchase or sale decision be discussed with a
financial adviser, or a broker-dealer, or a member of any financial
regulatory bodies. Investment in securities of the companies
discussed in this release is highly speculative and carries a high
degree of risk. WSICI is not liable for any investment decisions by
its readers or subscribers. Investors are cautioned that they may
lose all or a portion of their investment if they make a purchase
in WSICI profiled stocks.
This profile is not without bias, and is a paid release. To
comply with Section 17(b) of the Securities Act of 1933, WSICI is
disclosing that the company has been compensated for dissemination
of this information on behalf of one or more of the companies
mentioned in this release. For current services performed for
Southridge Enterprises Inc. (PINKSHEETS: SRGE), WSICI has been
compensated Fifty Thousand Dollars ($50,000.00), by third party
Cameroon Marketing Advisors Inc., who is a non-affiliated and may
hold a significant position in the stock.
FNM Disclosure: FN Media Group, LLC (FNMG)
is a news dissemination & third party publishing service
provider and is not affiliated or associated with
any company or entity mentioned or listed herein. If you're a
company interested in having FN Media Group assist you with
creating a greater awareness for your next news release utilizing
our multi-media and leading edge outreach solutions, contact us now
at info@financialnewsmedia.com. The material in this release is
intended to be strictly informational and is NEVER to be construed
or interpreted as a recommendation or research material, nor an
offer or solicitation to buy or sell securities. All readers are
strongly urged to perform research and due diligence on their own
and consult a licensed financial professional before considering
any level of investing in stocks. The companies that are discussed
in this release may or may not have approved the statements made
herein. For disseminating this release, FNMG was compensated one
thousand dollars for distribution of this release.
Contact Information: Wall Street Investor Communications, Inc.
Email Contact http://www.wallstreetinvestornews.com
MultiCell Technologies (CE) (USOTC:MCET)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
MultiCell Technologies (CE) (USOTC:MCET)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024